(NASDAQ: HOLX) Hologic's forecast annual revenue growth rate of 3.88% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Hologic's revenue in 2024 is $3,969,300,000.On average, 6 Wall Street analysts forecast HOLX's revenue for 2024 to be $944,269,747,076, with the lowest HOLX revenue forecast at $935,136,108,862, and the highest HOLX revenue forecast at $949,254,270,924. On average, 6 Wall Street analysts forecast HOLX's revenue for 2025 to be $990,796,820,779, with the lowest HOLX revenue forecast at $977,630,964,498, and the highest HOLX revenue forecast at $1,001,928,024,236.
In 2026, HOLX is forecast to generate $1,047,323,926,740 in revenue, with the lowest revenue forecast at $1,042,668,027,021 and the highest revenue forecast at $1,053,690,080,321.